Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion description "[Recently, the mTOR inhibitor everolimus was shown to be effective in the treatment of subependymal giant cell astrocytomas (a brain tumor) and renal AMLs (kidney tumors) in TSC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion evidence source_evidence_literature NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion SIO_000772 23733802 NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion wasDerivedFrom befree-20140225 NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_assertion wasGeneratedBy ECO_0000203 NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP757192.RAKA-DgxNm-nNaynSdkUtuDAhj8kf6Kkc-YJVQShTMDQc130_provenance.